Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,137,607 papers from all fields of science
Search
Sign In
Create Free Account
Nemorubicin Hydrochloride
Known as:
5,12-Naphthacenedione, 7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-10-((2,3,6-Trideoxy-3-((2S)-2-Methoxy-4-Morpholinyl)-Alpha-L-Lyxo-Hexopyranosyl)Oxy)-, Hydrochloride, (8S,10S)-
The hydrochloride salt form of nemorubicin, a morpholinyl analogue of the anthracycline doxorubicin with antineoplastic activity. Nemorubicin is…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
nemorubicin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Phase II trial of nemorubicin hydrochloride (N) in combination with cisplatin (cDDP) administered by intra-hepatic artery (IHA) in patients (pts) with hepatocellular carcinoma (HCC): Final results.
F. Izzo
,
T. Vogl
,
+9 authors
F. Fiore
2013
Corpus ID: 79077586
e15061 Background: N is a novel DNA-intercalator, mainly metabolized in liver by CYP3A4 enzyme and showing synergic antitumor…
Expand
2008
2008
Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC)
F. Fiore
,
C. Gadaleta
,
+7 authors
F. Izzo
2008
Corpus ID: 78596897
2572 Background: Nemorubicin is a novel DNA-intercalator with: in vivo synergistic antitumor activity with cDDP; a metabolic…
Expand
2007
2007
Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC)
F. Izzo
,
M. Grosso
,
+6 authors
F. Fiore
2007
Corpus ID: 85887369
A139 Background: Nemorubicin is a novel DNA-intercalator different from anthracyclines and other anticancer drugs. Its activity…
Expand
2006
2006
Phase I/II trial of nemorubicin hydrochloride in combination with cisplatin is supported by new preclinical evidences of its mechanism of action.
M. A. Pacciarini
,
C. Geroni
,
+5 authors
M. Broggini
Journal of Clinical Oncology
2006
Corpus ID: 36994258
14116 Background: Nemorubicin hydrochloride (nemorubicin) is a non-conventional anthracycline in Phase II evaluation in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE